Middle East & Africa Sarcopenia Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type (Vitamin D and Calcium Supplement, Protein Supplement, Vitamin B12 Supplement, and Others) and Distribution Channel (Pharmacies, Retail Channels, Online Channels, and Others)
The Middle East & Africa sarcopenia treatment market was valued at US$ 66.59 million in 2022 and is expected to reach US$ 90.55 million by 2030; it is estimated to register a CAGR of 3.9% from 2022... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe Middle East & Africa sarcopenia treatment market was valued at US$ 66.59 million in 2022 and is expected to reach US$ 90.55 million by 2030; it is estimated to register a CAGR of 3.9% from 2022 to 2030.Rising Awareness About Sarcopenia Bolster Middle East & Africa Sarcopenia Treatment Market The growing awareness of sarcopenia and its negative impact on health presents a significant scope for advancements in the fields of healthcare and geriatric care. Many advocacy groups and organizations are proactively taking steps to raise the awareness of sarcopenia among the masses. These organizations often work with medical professionals to keep the public updated on the various aspects of certain disorders, such as pathogenicity, target patients, prevention, and treatments, along with underlining the value of prompt diagnosis and treatment. In line with OWH's "Stronger than Sarcopenia" campaign, women are urged to discuss sarcopenia with their healthcare providers, followed by undergoing screen for the illness and taking appropriate therapy if required. Sarcopenia has been included in the curricula of medical schools and training programs for healthcare professionals such as physicians, nurses, and physical therapists. For example, the OWH worked with Medscape Education to create continuing medical education (CME) credits for healthcare professionals, which will better equip them to detect and treat sarcopenia in their patients. Mainstream media has expanded its coverage of sarcopenia to include articles, news stories, and documentaries. Thus, the elevating awareness regarding sarcopenia is likely to bring new growth trends into the sarcopenia treatment market in the coming years. Middle East & Africa Sarcopenia Treatment Market Overview The Middle East & Africa sarcopenic treatment market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA. The UAE and Saudi Arabia are among the most significant contributors to the market due to the rising incidence of orthopedic disorders. Increasing awareness among the large population about the use and benefits of nutritional supplements also benefits the market progress. An increased risk of sarcopenia in South Africa is associated with the aging population, and inadequate food security and nutrient intake brought on by poverty. The sarcopenia treatment market in this country is anticipated to be driven by a distinct population-specific approach taken by health authorities for the diagnosis, treatment, and prevention of sarcopenia. Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million) Middle East & Africa Sarcopenia Treatment Market Segmentation The Middle East & Africa sarcopenia treatment market is categorized into treatment type, distribution channel, and country. Based on treatment type, the Middle East & Africa sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest Middle East & Africa sarcopenia treatment market share in 2022. In terms of distribution channel, the Middle East & Africa sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest Middle East & Africa sarcopenia treatment market share in 2022. By country, the Middle East & Africa sarcopenia treatment market is segmented into Saudia Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa sarcopenia treatment market share in 2022. Abbott Laboratories, Bayer AG, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp, and GSK Plc are some of the leading companies operating in the Middle East & Africa sarcopenia treatment market. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics 4.1 Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics 4.2 Market Drivers 4.2.1 Upsurge in Geriatric Population 4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults 4.3 Key Market Restraints: 4.3.1 Unavailability of Direct Interventions 4.4 Key Market Opportunities: 4.4.1 Products in Clinical Trial Phases 4.5 Future Trends: 4.5.1 Rising Awareness About Sarcopenia 4.6 Impact of Drivers and Restraints: 5. Sarcopenia Treatment Market - Middle East & Africa Market Analysis 5.1 Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030 5.2 Middle East & Africa Sarcopenia Treatment Market Forecast and Analysis 6. Middle East & Africa Sarcopenia Treatment Market Analysis - By Treatment Type 6.1 Vitamin D and Calcium Supplement 6.1.1 Overview 6.1.2 Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 6.2 Protein Supplement 6.2.1 Overview 6.2.2 Protein Supplement : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 6.3 Vitamin B12 Supplement 6.3.1 Overview 6.3.2 Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 6.4 Others 6.4.1 Overview 6.4.2 Others : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 7. Middle East & Africa Sarcopenia Treatment Market Analysis - By Distribution Channel 7.1 Pharmacies 7.1.1 Overview 7.1.2 Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million) 7.2 Retail Channels 7.2.1 Overview 7.2.2 Retail Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 7.3 Online Channels 7.3.1 Overview 7.3.2 Online Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 7.4 Others 7.4.1 Overview 7.4.2 Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million) 8. Middle East & Africa Sarcopenia Treatment Market - Country Analysis 8.1 Middle East & Africa 8.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country 8.1.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country 8.1.1.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn) 8.1.1.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type 8.1.1.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel 8.1.1.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn) 8.1.1.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type 8.1.1.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel 8.1.1.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn) 8.1.1.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type 8.1.1.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel 8.1.1.5 Rest of Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn) 8.1.1.5.1 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Treatment Type 8.1.1.5.2 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Distribution Channel 9. Sarcopenia Treatment Market-Industry Landscape 9.1 Overview 9.2 Growth Strategies in the Sarcopenia Treatment Market 9.3 Inorganic Growth Strategies 9.3.1 Overview 9.4 Organic Growth Strategies 9.4.1 Overview 10. Company Profiles 10.1 Abbott Laboratories 10.1.1 Key Facts 10.1.2 Business Description 10.1.3 Products and Services 10.1.4 Financial Overview 10.1.5 SWOT Analysis 10.1.6 Key Developments 10.2 Bayer AG 10.2.1 Key Facts 10.2.2 Business Description 10.2.3 Products and Services 10.2.4 Financial Overview 10.2.5 SWOT Analysis 10.2.6 Key Developments 10.3 Nestle Health Science SA 10.3.1 Key Facts 10.3.2 Business Description 10.3.3 Products and Services 10.3.4 Financial Overview 10.3.5 SWOT Analysis 10.3.6 Key Developments 10.4 Novartis AG 10.4.1 Key Facts 10.4.2 Business Description 10.4.3 Products and Services 10.4.4 Financial Overview 10.4.5 SWOT Analysis 10.4.6 Key Developments 10.5 Pfizer Inc 10.5.1 Key Facts 10.5.2 Business Description 10.5.3 Products and Services 10.5.4 Financial Overview 10.5.5 SWOT Analysis 10.5.6 Key Developments 10.6 Sanofi SA 10.6.1 Key Facts 10.6.2 Business Description 10.6.3 Products and Services 10.6.4 Financial Overview 10.6.5 SWOT Analysis 10.6.6 Key Developments 10.7 Amway Corp 10.7.1 Key Facts 10.7.2 Business Description 10.7.3 Products and Services 10.7.4 Financial Overview 10.7.5 SWOT Analysis 10.7.6 Key Developments 10.8 GSK Plc 10.8.1 Key Facts 10.8.2 Business Description 10.8.3 Products and Services 10.8.4 Financial Overview 10.8.5 SWOT Analysis 10.8.6 Key Developments 11. Appendix 11.1 About The Insight Partners 11.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポートThe Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(channel)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/08 10:26 148.90 円 163.91 円 197.75 円 |